Market overview
The global smart breast imaging market is worth USD 366 mn in 2026 and is forecast to reach USD 2.1 bn by 2036, growing at a 19.0% CAGR. United States is the largest country market and Mammography and tomosynthesis is the largest by modality segment.
| Scope | Artificial-intelligence software that reads mammograms, tomosynthesis, breast ultrasound and MRI to detect cancer and assess density, licensed to screening programmes and imaging centres. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 300 mn |
| Value 2026 | USD 366 mn |
| Value 2036 | USD 2.1 bn |
| CAGR 2026-2036 | 19.0% |
| Volume 2026 | 24.9 million exams |
| Volume 2036 | 174 million exams |
| Average price 2026 | USD 14.7 per exam |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Smart Breast Imaging market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 366 mn |
| 2027 | USD 436 mn |
| 2028 | USD 518 mn |
| 2029 | USD 617 mn |
| 2030 | USD 734 mn |
| 2031 | USD 873 mn |
| 2032 | USD 1.0 bn |
| 2033 | USD 1.2 bn |
| 2034 | USD 1.5 bn |
| 2035 | USD 1.8 bn |
| 2036 | USD 2.1 bn |
Smart Breast Imaging market segmentation
By modality
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Mammography and tomosynthesis | 68.0% | 62.0% | USD 249 mn | 17.9% |
| Breast ultrasound | 18.0% | 22.9% | USD 66 mn | 21.9% |
| Breast MRI and others | 14.0% | 15.1% | USD 51 mn | 19.9% |
By function
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Detection and triage | 52.0% | 49.5% | USD 190 mn | 18.4% |
| Density and risk assessment | 28.0% | 31.5% | USD 102 mn | 20.4% |
| Workflow and reporting | 20.0% | 19.0% | USD 73 mn | 18.4% |
By software class
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Computer-aided detection | 34.0% | 28.0% | USD 124 mn | 16.7% |
| AI triage and workflow | 28.0% | 32.0% | USD 102 mn | 20.6% |
| Risk prediction | 20.0% | 22.0% | USD 73 mn | 20.1% |
| Automated breast ultrasound AI | 18.0% | 18.0% | USD 66 mn | 19.0% |
By deployment
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Cloud | 44.0% | 58.0% | USD 161 mn | 22.3% |
| On-premises | 40.0% | 28.0% | USD 146 mn | 14.8% |
| Hybrid | 16.0% | 14.0% | USD 59 mn | 17.4% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 48.0% | 44.0% | USD 176 mn | 18.0% |
| Imaging centres | 30.0% | 32.0% | USD 110 mn | 19.8% |
| Screening programs | 22.0% | 24.0% | USD 81 mn | 20.0% |
Top 25 countries for smart breast imaging by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 89.5% of 2026 revenue and the 25 countries below together hold 96.8%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 161 mn | 44.0% | USD 796 mn | 17.3% |
| 2 | United Kingdom | USD 33 mn | 9.0% | USD 192 mn | 19.3% |
| 3 | Germany | USD 26 mn | 7.0% | USD 150 mn | 19.3% |
| 4 | South Korea | USD 22 mn | 6.0% | USD 152 mn | 21.4% |
| 5 | France | USD 18 mn | 5.0% | USD 106 mn | 19.2% |
| 6 | Netherlands | USD 15 mn | 4.0% | USD 85 mn | 19.3% |
| 7 | Japan | USD 15 mn | 4.0% | USD 85 mn | 19.3% |
| 8 | China | USD 15 mn | 4.0% | USD 152 mn | 26.4% |
| 9 | Sweden | USD 13 mn | 3.5% | USD 75 mn | 19.3% |
| 10 | Australia | USD 11 mn | 3.0% | USD 65 mn | 19.4% |
| 11 | Italy | USD 6.0 mn | 1.6% | USD 33 mn | 18.6% |
| 12 | Spain | USD 3.5 mn | 1.0% | USD 19 mn | 18.5% |
| 13 | Canada | USD 2.6 mn | 0.7% | USD 14 mn | 18.5% |
| 14 | Switzerland | USD 2.1 mn | 0.6% | USD 11 mn | 18.4% |
| 15 | India | USD 1.8 mn | 0.5% | USD 14 mn | 22.8% |
| 16 | Belgium | USD 1.6 mn | 0.4% | USD 8.6 mn | 18.4% |
| 17 | Denmark | USD 1.4 mn | 0.4% | USD 7.5 mn | 18.4% |
| 18 | Brazil | USD 1.2 mn | 0.3% | USD 9.8 mn | 22.9% |
| 19 | Taiwan | USD 1.1 mn | 0.3% | USD 6.2 mn | 18.6% |
| 20 | Austria | USD 1.1 mn | 0.3% | USD 5.8 mn | 18.6% |
| 21 | Turkey | USD 0.99 mn | 0.3% | USD 7.7 mn | 22.8% |
| 22 | Poland | USD 0.92 mn | 0.2% | USD 7.3 mn | 23.1% |
| 23 | Mexico | USD 0.88 mn | 0.2% | USD 6.9 mn | 22.9% |
| 24 | Norway | USD 0.84 mn | 0.2% | USD 4.6 mn | 18.5% |
| 25 | Thailand | USD 0.77 mn | 0.2% | USD 6.0 mn | 22.9% |
| Rest of world | USD 12 mn | 3.2% | USD 63 mn | 18.4% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Hologic
- Lunit
- RadNet
- GE HealthCare
Group 2: Regional and specialist players
- ScreenPoint Medical
- Therapixel
- Vara
- Kheiron Medical
- Whiterabbit.ai
- CureMetrix
- MeVis Medical Solutions
- Clairity
Group 3: Emerging and niche players
- Koios Medical
- Densitas
- MedCognetics
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the smart breast imaging market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 19.0% is calculated from the resulting values.
The market is divided by modality, by function, by software class, by deployment, by end user. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the smart breast imaging market?
The global smart breast imaging market is estimated at USD 300 mn in 2025 and USD 366 mn in 2026.
How fast will the smart breast imaging market grow?
It is forecast to reach USD 2.1 bn by 2036, a compound annual growth rate of 19.0% from 2026, an increase of USD 1.7 bn.
Which country is the largest market for smart breast imaging?
United States is the largest market by revenue at USD 161 mn in 2026, 44.0% of the global total. The three largest countries together hold 60.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 26.4% a year from 2026 to 2036.
Which smart breast imaging segment is largest?
In the by modality split, Mammography and tomosynthesis is the largest segment with 68.0% of 2026 revenue.
Who are the leading smart breast imaging companies?
Global leaders include Hologic, Lunit, RadNet, GE HealthCare.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- CRISPR-Integrated Gene Editing Delivery DevicesUSD 366 mn · 10.5% CAGR
- Adaptive StrollerUSD 362 mn · 6.0% CAGR
- Veterinary Dental EquipmentUSD 371 mn · 5.8% CAGR
- Dental AutoclavesUSD 355 mn · 4.5% CAGR
- Mixed Reality Navigation PlatformsUSD 378 mn · 17.0% CAGR
- AI-Assisted Clinical Trial Protocol DesignUSD 378 mn · 20.0% CAGR
- UV-C Disinfection RobotsUSD 382 mn · 7.0% CAGR
- MRI-based Quantitative BiomarkersUSD 348 mn · 15.0% CAGR